Vital3D Technologies

Executive Summary

Vital3D Technologies is a Brussels-based tissue engineering startup founded in 2017, dedicated to addressing the critical shortage of transplantable organs and accelerating drug development through innovative biotechnology solutions. By blending biology and technology, the company aims to create accessible, cutting-edge products that transform healthcare. Although still in early private stages with no disclosed funding or pipeline, Vital3D operates in the rapidly advancing field of tissue engineering, which has significant potential to revolutionize organ transplantation and pharmaceutical testing. The company's focus on accessible solutions positions it well for future growth, contingent on successful R&D milestones and securing investment.

Upcoming Catalysts (preview)

• Q4 2026Series A Funding Round65% success
• H1 2027Preclinical Proof-of-Concept Data Release50% success
• Q2 2027Strategic Partnership with Pharmaceutical Company40% success